MADISON HINKLEDIRE: Open Payments
NPI 1306551247 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$116 in 7 payments from 5 companies in 2025. Trend: 2023 $231 · 2024 $339 · 2025 $116
Food & beverage: $116
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $22 |
| MILLICENT US INC | 1 | $15 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
Products named: Veozah, GEMTESA, INTRAROSA, MYFEMBREE, ACCRUFER.
Industry payments across PA — which companies pay providers there.
